The Beckley Foundation’s Scientific Programme, led by Amanda Feilding, develops and conducts psychedelic research through an international network of collaborative partnerships with leading scientists and institutions. Studies focus on cannabis, psychedelics (psilocybin, LSD, ayahuasca, DMT, and 5MeO-DMT), and MDMA. We investigate the action of these substances in the human brain, using the latest developments in neuroscience and brain imaging technology. Our research and clinical trials aim to increase our understanding of consciousness, and to use this knowledge to treat mental and physical illness, expand awareness, and enhance well-being and creativity.
Psilocybin for Depression
Type of publication